IBTK expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.244200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.853400E-01
Normal-vs-Stage2
8.136800E-01
Normal-vs-Stage3
9.038200E-02
Normal-vs-Stage4
3.201000E-01
Stage1-vs-Stage2
9.395200E-01
Stage1-vs-Stage3
3.661200E-01
Stage1-vs-Stage4
3.921600E-01
Stage2-vs-Stage3
2.703600E-01
Stage2-vs-Stage4
2.269600E-01
Stage3-vs-Stage4
2.629800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.241000E-01
Normal-vs-AfricanAmerican
7.397400E-01
Normal-vs-Asian
4.859200E-01
Caucasian-vs-AfricanAmerican
3.178600E-01
Caucasian-vs-Asian
3.467800E-01
AfricanAmerican-vs-Asian
2.318800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.234600E-01
Normal-vs-Female
8.455800E-01
Male-vs-Female
8.669400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.423200E-01
Normal-vs-Age(41-60Yrs)
9.540200E-01
Normal-vs-Age(61-80Yrs)
7.865000E-01
Normal-vs-Age(81-100Yrs)
8.325400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.049200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.039600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.003400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.240600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.186400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.431200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.077000E-01
Normal-vs-Daily Drinker
1.701170E-01
Normal-vs-Weekly Drinker
7.570400E-01
Normal-vs-Occasional Drinker
9.871400E-01
Normal-vs-Social Drinker
8.105200E-01
Non Drinker-vs-Daily Drinker
1.640350E-01
Non Drinker-vs-Weekly Drinker
6.354800E-01
Non Drinker-vs-Occasional Drinker
1.839810E-01
Non Drinker-vs-Social Drinker
1.142790E-01
Daily Drinker-vs-Weekly Drinker
1.309640E-01
Daily Drinker-vs-Occasional Drinker
1.355950E-02
Daily Drinker-vs-Social Drinker
3.471800E-02
Weekly Drinker-vs-Occasional Drinker
5.469600E-01
Weekly Drinker-vs-Social Drinker
3.896400E-01
Occasional Drinker-vs-Social Drinker
6.348200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.427430E-01
Normal-vs-Grade 2
8.959700E-02
Normal-vs-Grade 3
8.982100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.604200E-01
Grade 1-vs-Grade 3
9.643600E-01
Grade 1-vs-Grade 4
1.427430E-01
Grade 2-vs-Grade 3
2.995200E-01
Grade 2-vs-Grade 4
8.959700E-02
Grade 3-vs-Grade 4
8.982100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.103800E-01
Normal-vs-NonDiabetic
5.846000E-01
Diabetic-vs-NonDiabetic
9.276200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.082800E-01
Normal-vs-NoPancreatitis
6.856400E-01
Pancreatitis-vs-NoPancreatitis
2.243000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.905000E-01
Normal-vs-N1
7.566800E-01
N0-vs-N1
2.966800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.129400E-01
Normal-vs-TP53-NonMutant
7.514600E-01
TP53-Mutant-vs-TP53-NonMutant
4.088600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
